Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
CPT: Pharmacometrics & Systems Pharmacology|February 20, 2021
Opportunities and challenges for applying model-informed drug development approaches to gene therapiesArtur Belov, Kimberly Schultz, Richard Forshee, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 26, 2020
Comparing clotting factors attributes across different methods of preference elicitation in haemophilia patientsMillion A Tegenge, Artur Belov, Megan Moncur, et al.
Transfusion|April 19, 2022
Analyzing real world data of blood transfusion adverse events: Opportunities and challengesPerrin Jhaveri, Selen Bozkurt, Axel Moyal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2022
Modeling the Risk of HIV Transfusion TransmissionArtur Belov, Hong Yang, Richard A Forshee, et al.
Vaccines|November 25, 2023
Trends in Influenza Vaccination Rates among a Medicaid Population from 2016 to 2021Behzad Naderalvojoud, Nilpa D Shah, Jane N Mutanga, et al.
Transfusion|May 30, 2023
Novel computational methods on electronic health record yields new estimates of transfusion-associated circulatory overload in populations enriched with high-risk patientsMichelle Wang, Gregory M Goldgof, Ayan Patel, et al.
Transfusion|October 6, 2025
Prevalence of HIV, HBV, and HCV in United States blood donations, 2015-2023: The transfusion-transmissible infections monitoring system (TTIMS)Emilya Huseynova, James Haynes, Edward P Notari, et al.
Transfusion|August 25, 2022
Detection of allergic transfusion-related adverse events from electronic medical recordsBarbee Whitaker, Jeno Pizarro, Matthew Deady, et al.
Frontiers in Digital Health|January 10, 2022
The Food and Drug Administration Biologics Effectiveness and Safety Initiative Facilitates Detection of Vaccine Administrations From Unstructured Data in Medical Records Through Natural Language ProcessingMatthew Deady, Hussein Ezzeldin, Kerry Cook, et al.
Transfusion|September 8, 2025
Incidence and window period residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2017 to 2023: The transfusion-transmissible infections monitoring systemEmilya Huseynova, James Haynes, Edward P Notari, et al.
Pageof 2